- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/16 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 263/16
Total number of patents in this class: 54
10-year publication summary
|
3
|
6
|
6
|
5
|
2
|
2
|
1
|
5
|
1
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Duke University | 3181 |
6 |
| The University of North Carolina at Chapel Hill | 2114 |
4 |
| Blade Therapeutics, Inc. | 15 |
3 |
| The Broad Institute, Inc. | 1986 |
3 |
| Chevron Phillips Chemical Company LP | 1862 |
3 |
| Janssen Pharmaceutica N.V. | 3160 |
2 |
| FMC Corporation | 810 |
2 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3330 |
2 |
| Ligand Pharmaceuticals Incorporated | 168 |
2 |
| SpiroChem AG | 4 |
2 |
| Universite de Bourgogne | 174 |
2 |
| EuroChem Antwerpen | 18 |
2 |
| Merck Sharp & Dohme LLC | 3737 |
2 |
| F. Hoffmann-La Roche AG | 7808 |
1 |
| BASF SE | 21306 |
1 |
| Boehringer Ingelheim International GmbH | 4486 |
1 |
| Syngenta Participations AG | 1495 |
1 |
| Massachusetts Institute of Technology | 10282 |
1 |
| Sumitomo Chemical Company, Limited | 8968 |
1 |
| ADAMA Agan Ltd. | 446 |
1 |
| Other owners | 12 |